Sex-specific risk factors associated with graves' orbitopathy in Korean patients with newly diagnosed graves' disease

被引:0
|
作者
Lee, Jooyoung [1 ]
Kang, Jinmo [1 ]
Ahn, Hwa Young [2 ]
Lee, Jeong Kyu [3 ]
机构
[1] Chung Ang Univ, Dept Appl Stat, Seoul, South Korea
[2] Chung Ang Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[3] Chung Ang Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
THYROID-ASSOCIATED OPHTHALMOPATHY; MULTIPLE IMPUTATION; SEVERITY; SMOKING; AGE;
D O I
10.1038/s41433-023-02513-z
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
ObjectiveTo assess sex-specific risk factors for Graves' orbitopathy (GO) in newly diagnosed Graves' disease (GD) patients.MethodsA retrospective cohort study was conducted using the National Health Insurance Service's sample database, which consisted of 1,137,861 subjects from 2002 to 2019. The international classification of disease-10 codes was used to identify those who developed GD (E05) and GO (H062). A multivariable Cox proportional hazards model was used to estimate the effect of risk factors on GO development.ResultsAmong 2145 male and 5047 female GD patients, GO occurred in 134 men (6.2%) and 293 women (5.8%). A multivariable Cox regression model revealed that GO development was significantly associated with younger age (HR = 0.84, 95% CI = 0.73-0.98), low income (HR = 0.55, 95% CI = 0.35-0.86), and heavy drinking (HR = 1.79, 95% CI = 1.10-2.90) in men, and with younger age (HR = 0.89, 95% CI = 0.81-0.98), lower body mass index (HR = 0.55, 95% CI = 0.33-0.90), high total cholesterol (HR = 1.04, 95% CI = 1.01-1.06), hyperlipidaemia (HR = 1.37, 95% CI = 1.02-1.85), and lower statin dose (HR = 0.37, 95% CI = 0.22-0.62) in women. There was no association between smoking and GO development in both men and women.ConclusionsThe risk factors for GO development were sex-dependent. These results show the need for more sophisticated attention and support considering sex characteristics in GO surveillance.
引用
收藏
页码:3382 / 3391
页数:10
相关论文
共 50 条
  • [1] Sex-specific risk factors associated with graves’ orbitopathy in Korean patients with newly diagnosed graves’ disease
    Jooyoung Lee
    Jinmo Kang
    Hwa Young Ahn
    Jeong Kyu Lee
    Eye, 2023, 37 : 3382 - 3391
  • [2] Statins Decrease the Risk of Orbitopathy in Newly Diagnosed Patients with Graves Disease
    Nilsson, Anton
    Tsoumani, Kleoniki
    Planck, Tereza
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (05): : 1325 - 1332
  • [3] Factors Associated with the Duration of Graves' Orbitopathy Activity in Patients with Graves' disease
    Gaberscek, S.
    Sfiligoj, D.
    Zaletel, K.
    Pirnat, E.
    Mekjavic, P. Jaki
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S154 - S155
  • [4] Factors associated with severity of orbitopathy in patients with Graves' disease
    Nabi, Tauseef
    Rafiq, Nadeema
    TAIWAN JOURNAL OF OPHTHALMOLOGY, 2020, 10 (03) : 197 - 202
  • [5] The potential markers involved in newly diagnosed graves' disease and the development of active graves' orbitopathy
    He, Mingqian
    Wang, Yue
    Wang, Jingya
    Sui, Jing
    Ding, Xi
    Chen, Ziyi
    Zhang, Meng
    Zhao, Yang
    Xie, Baosong
    Shi, Bingyin
    CYTOKINE, 2020, 127
  • [6] Predictive score for the development or progression of Graves' orbitopathy in patients with newly diagnosed Graves' hyperthyroidism
    Wiersinga, Wilmar
    Zarkovic, Milos
    Bartalena, Luigi
    Donati, Simone
    Perros, Petros
    Okosieme, Onyebuchi
    Morris, Daniel
    Fichter, Nicole
    Lareida, Jurg
    von Arx, Georg
    Daumerie, Chantal
    Burlacu, Maria-Christina
    Kahaly, George
    Pitz, Susanne
    Beleslin, Biljana
    Ciric, Jasmina
    Ayvaz, Goksun
    Konuk, Onur
    Toruner, Fusun Balos
    Salvi, Mario
    Covelli, Danila
    Curro, Nicola
    Hegedus, Laszlo
    Brix, Thomas
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2018, 178 (06) : 635 - 643
  • [7] Factors Associated with the Occurrence of Graves' Orbitopathy after Radioiodine Therapy in Patients with Graves' disease
    Gaberscek, S.
    Sfiligoj, D.
    Zaletel, K.
    Pirnat, E.
    Mekjavic, P. Jaki
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S154 - S154
  • [8] Prevention of Graves' Orbitopathy: Early Diagnosis of Thyroid-Associated Orbitopathy in Graves' Disease
    Mourits, Maarten P.
    ORBIT-AN INTERNATIONAL JOURNAL ON ORBITAL DISORDERS AND FACIAL RECONSTRUCTIVE SURGERY, 2008, 27 (06): : 399 - 400
  • [9] Comment on "factors associated with severity of orbitopathy in patients with Graves' disease (Author Reply)
    Nabi, Tauseef
    Rafiq, Nadeema
    TAIWAN JOURNAL OF OPHTHALMOLOGY, 2022, 12 (01) : 118 - 119
  • [10] Prevalence and Natural History of Graves' Orbitopathy in a Large Series of Patients With Newly Diagnosed Graves' Hyperthyroidism Seen at a Single Center
    Tanda, M. L.
    Piantanida, E.
    Liparulo, L.
    Veronesi, G.
    Lai, A.
    Sassi, L.
    Pariani, N.
    Gallo, D.
    Azzolini, C.
    Ferrario, M.
    Bartalena, L.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (04): : 1443 - 1449